Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Alnylam Pharmaceuticals (ALNY)

Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,470,076
  • Shares Outstanding, K 128,981
  • Annual Sales, $ 1,828 M
  • Annual Income, $ -440,240 K
  • EBIT $ -188 M
  • EBITDA $ -91 M
  • 60-Month Beta 0.32
  • Price/Sales 17.32
  • Price/Cash Flow N/A
  • Price/Book 978.47

Options Overview Details

View History
  • Implied Volatility 36.06% ( +0.75%)
  • Historical Volatility 39.70%
  • IV Percentile 13%
  • IV Rank 3.21%
  • IV High 149.76% on 06/21/24
  • IV Low 32.29% on 06/26/24
  • Put/Call Vol Ratio 0.09
  • Today's Volume 731
  • Volume Avg (30-Day) 401
  • Put/Call OI Ratio 0.98
  • Today's Open Interest 24,194
  • Open Int (30-Day) 24,171

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.65
  • Number of Estimates 12
  • High Estimate -0.21
  • Low Estimate -1.40
  • Prior Year -1.10
  • Growth Rate Est. (year over year) +40.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
229.85 +7.28%
on 11/18/24
258.12 -4.47%
on 12/09/24
+11.02 (+4.68%)
since 11/15/24
3-Month
229.85 +7.28%
on 11/18/24
304.39 -18.99%
on 10/17/24
-27.88 (-10.16%)
since 09/17/24
52-Week
141.98 +73.68%
on 04/25/24
304.39 -18.99%
on 10/17/24
+61.34 (+33.11%)
since 12/15/23

Most Recent Stories

More News
Insider Sale: CMO & EVP Dev & Med Affairs of $ALNY (ALNY) Sells 1 Shares

Pushkal Garg, the CMO & EVP Dev & Med Affairs of $ALNY ($ALNY), sold 1 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.0%...

ALNY : 246.58 (+1.06%)
FDA Accepts GSK's Filing for Expanded Use of Nucala in COPD

GSK plc GSK announced that the FDA has accepted its regulatory filing, seeking the approval of a new indication for Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD) treatment for...

ALNY : 246.58 (+1.06%)
GILD : 92.80 (+0.81%)
GSK : 34.23 (+1.94%)
PFE : 26.43 (+4.67%)
Stocks Retreat as Bond Yields Spike Higher

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.29%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.17%. Stock indexes...

TAP : 59.25 (-0.59%)
DHI : 146.71 (-0.61%)
ABNB : 132.24 (+0.03%)
$IUXX : 22,001.08 (-0.43%)
ELV : 366.30 (-1.88%)
ZNH25 : 109-295 (+0.01%)
SHOP : 119.49 (+3.06%)
PHM : 115.89 (-0.80%)
NGNE : 23.72 (-5.61%)
KNX : 53.94 (-1.78%)
$DOWI : 43,449.90 (-0.61%)
SPY : 604.29 (-0.41%)
Stocks Slightly Lower as Indexes Consolidate Recent Rally

The S&P 500 Index ($SPX ) (SPY ) today is down -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.07%. Stock indexes today are slightly...

NVDA : 130.39 (-1.22%)
TWLO : 109.76 (-1.64%)
$SPX : 6,050.61 (-0.39%)
HON : 233.13 (-1.22%)
ALNY : 246.58 (+1.06%)
LYV : 137.86 (+0.02%)
ABNB : 132.24 (+0.03%)
CAH : 115.82 (-0.63%)
$IUXX : 22,001.08 (-0.43%)
ELV : 366.30 (-1.88%)
TSN : 59.40 (-0.57%)
QQQ : 535.80 (-0.44%)
Stock Indexes Slightly Higher as They Consolidate Below Record Highs

The S&P 500 Index ($SPX ) (SPY ) today is up +0.09%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.02%. Stocks today are slightly higher,...

NVDA : 130.39 (-1.22%)
TWLO : 109.76 (-1.64%)
$SPX : 6,050.61 (-0.39%)
HON : 233.13 (-1.22%)
ALNY : 246.58 (+1.06%)
LYV : 137.86 (+0.02%)
ABNB : 132.24 (+0.03%)
$IUXX : 22,001.08 (-0.43%)
TSN : 59.40 (-0.57%)
QQQ : 535.80 (-0.44%)
ZNH25 : 109-295 (+0.01%)
MOS : 25.44 (-1.55%)
Alnylam: Q3 Earnings Snapshot

Alnylam: Q3 Earnings Snapshot

ALNY : 246.58 (+1.06%)
Gilead, MRK Report Data From Investigational Combination Study for HIV

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational combination of islatravir and lenacapavir for the treatment of HIV.Data showed...

MRK : 100.06 (unch)
ALNY : 246.58 (+1.06%)
GILD : 92.80 (+0.81%)
GSK : 34.23 (+1.94%)
Here's Why You Should Add ALNY Stock to Your Portfolio Right Now

Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of experimental RNAi therapeutics is focused on three strategic therapeutic areas...

ALNY : 246.58 (+1.06%)
NVS : 99.10 (+1.36%)
REGN : 740.01 (+2.09%)
RHHBY : 35.8400 (+0.84%)
Stocks Finish Higher as Economic News Shows Economy Holding Up

The S&P 500 Index ($SPX ) (SPY ) Friday closed up +1.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.29%. Stocks on Friday settled...

$SPX : 6,050.61 (-0.39%)
SPY : 604.29 (-0.41%)
$DOWI : 43,449.90 (-0.61%)
DIA : 435.57 (-0.64%)
$IUXX : 22,001.08 (-0.43%)
QQQ : 535.80 (-0.44%)
ZNH25 : 109-295 (+0.01%)
INTC : 20.44 (-1.87%)
APA : 21.05 (-4.06%)
FANG : 160.14 (+0.76%)
HAL : 27.19 (-2.44%)
SLB : 38.93 (-2.38%)
Stocks Mixed on Positive Economic News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.28%. Stocks are mixed today. Intel...

$SPX : 6,050.61 (-0.39%)
SPY : 604.29 (-0.41%)
$DOWI : 43,449.90 (-0.61%)
DIA : 435.57 (-0.64%)
$IUXX : 22,001.08 (-0.43%)
QQQ : 535.80 (-0.44%)
ZNH25 : 109-295 (+0.01%)
INTC : 20.44 (-1.87%)
APA : 21.05 (-4.06%)
SLB : 38.93 (-2.38%)
COP : 98.26 (-1.32%)
DVN : 32.17 (-1.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Alnylam Pharmaceuticals Inc. is a development-stage biopharmaceutical company focused on the development of novel therapeutics based on RNA interference. The company's pipeline of experimental RNAi therapeutics is focused across three strategic therapeutic areas - genetic medicines, cardio-metabolic...

See More

Key Turning Points

3rd Resistance Point 259.80
2nd Resistance Point 254.69
1st Resistance Point 250.63
Last Price 246.58
1st Support Level 241.47
2nd Support Level 236.36
3rd Support Level 232.31

See More

52-Week High 304.39
Last Price 246.58
Fibonacci 61.8% 242.35
Fibonacci 50% 223.18
Fibonacci 38.2% 204.02
52-Week Low 141.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar